Press release
Evolving Market Trends In The Attention Deficit Hyperactivity Disorder Industry: JAMP Pharma Group Expands ADHD Treatment Options With Launch Of Guanfacine XR
Attention Deficit Hyperactivity Disorder
What Is the Expected Attention Deficit Hyperactivity Disorder Market Size During the Forecast Period?
In recent times, the market size for attention deficit hyperactivity disorder has experienced significant growth. It is projected to expand from $16.29 billion in 2024 to $17.43 billion in 2025, with a compound annual growth rate (CAGR) of 7.0%. The historic growth is primarily due to the increasing rates of ADHD, a rise in ADHD cases among children, and a greater understanding of the disorder. Factors like increasing healthcare expenditure and government-led initiatives aimed at increased mental health awareness, have also contributed to its growth.
The market size for attention deficit hyperactivity disorder is predicted to experience robust expansion in the coming years, potentially reaching $22.59 billion in 2029 with a compound annual growth rate (CAGR) of 6.7%. The predicted growth during the forecast period is linked to the increasing number of pediatric and adult patients undergoing treatment, sophisticated healthcare infrastructure, surging implementation of personalized medicine, recognition of mental health issues, and increased use of additives and preservatives in children's meals. The major trends for the forecast period consist of technological enhancements and innovative treatments, progression in diagnosis and treatment strategies, introduction of new therapeutic drugs, a shift towards non-stimulant drugs, and advancement in pharmaceutical treatments.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21108
What Are the High-Growth Segments in the Attention Deficit Hyperactivity Disorder Market?
The attention deficit hyperactivity disorder market covered in this report is segmented -
1) By Type: Stimulants, Non-Stimulants
2) By Age Group: Children, Adults
3) By Gender: Male, Female
4) By Dosage Form: Tablets, Capsules, Other Dosage Forms
5) By Distribution Channel: Retail Pharmacy, Hospital Pharmacy, Online Pharmacy
Subsegments:
1) By Stimulants: Methylphenidate-based Medications, Amphetamine-based Medications, Mixed Amphetamine Salts, Dexmethylphenidate
2) By Non-Stimulants: Atomoxetine (Strattera), Guanfacine (Intuniv), Clonidine (Kapvay), Bupropion (Wellbutrin)
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21108&type=smp
What Key Drivers Are Expected to Influence Future Attention Deficit Hyperactivity Disorder Market Growth?
The surge in personalized medicine adoption is expected to boost the advancement of the attention deficit hyperactivity disorder (ADHD) market. Personalized medicine, a technique in healthcare that modifies treatments based on a person's genetic, environmental, and lifestyle elements, is being embraced due to the progress in genomics technologies. These technologies allow for the customization of treatments considering a person's genetic make-up, thereby resulting in more specific and successful therapies. By taking into account a person's unique genetic, environmental and behavioral traits, ADHD plays a significant role in personalized medicine, enabling the design of customized treatment strategies, leading to more precise and effective interventions. For example, according to a study by the US-based non-profit organization, the Personalized Medicine Coalition (PMC) in February 2024, personalized medicines constituted over one-third of new FDA drug approvals for the fourth consecutive year in 2023. The FDA granted approval to 16 new personalized treatments for rare diseases (an increase from 6 in 2022), 7 cancer drugs and 3 for other diseases. As a result, the escalating adoption of personalized medicine is the catalyst for the growth of the attention deficit hyperactivity disorder market.
Which Companies Hold the Largest Share Across Different Attention Deficit Hyperactivity Disorder Market Segments?
Major companies operating in the attention deficit hyperactivity disorder market are Pfizer Inc., Johnson & Johnson, AstraZeneca PLC, Novartis International AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Supernus Pharmaceuticals Inc., Neos Therapeutics Inc., Collegium Pharmaceutical Inc., Mallinckrodt Pharmaceuticals plc, Tris Pharma Inc., Arbor Pharmaceuticals LLC, Akili Interactive Labs Inc., Mind Medicine (MindMed) Inc., NeuroSigma Inc., KemPharm Inc., RespireRx Pharmaceuticals Inc., Cingulate Therapeutics LLC, Adlon Therapeutics L.P.
What Attention Deficit Hyperactivity Disorder Market Trends Are Gaining Traction Across Different Segments?
Leading corporations in the ADHD market are emphasizing the development of innovative medicines such as extended-release tablets to advance treatment efficiency, patient cooperation, and offer prolonged symptom management. These tablets slowly release medicine over time, maintaining steady symptom control throughout the day with just one dose. This reduces the requirement for numerous dosages and enhances convenience, ensuring successful adherence to the treatment regimen for individuals with ADHD. For example, JAMP Pharma Group, a pharmaceutical company based in Canada, introduced Guanfacine XR, a generic version of Takeda Canada Inc.'s INTUNIV XR, in February 2022. This drug, meant for treating ADHD, is an extended-release form of guanfacine that operates by influencing certain receptors in the brain to enhance attention, impulse control, and hyperactivity. The medication is offered in several strengths (1 mg, 2 mg, 3 mg, and 4 mg) and is provided in a bottle of 100, thus allowing flexibility in treatment.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/attention-deficit-hyperactivity-disorder-global-market-report
What Are the Emerging Geographies for The Attention Deficit Hyperactivity Disorder Market Growth?
North America was the largest region in the attention deficit hyperactivity disorder market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the attention deficit hyperactivity disorder market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Attention Deficit Hyperactivity Disorder Market?
2. What is the CAGR expected in the Attention Deficit Hyperactivity Disorder Market?
3. What Are the Key Innovations Transforming the Attention Deficit Hyperactivity Disorder Industry?
4. Which Region Is Leading the Attention Deficit Hyperactivity Disorder Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Evolving Market Trends In The Attention Deficit Hyperactivity Disorder Industry: JAMP Pharma Group Expands ADHD Treatment Options With Launch Of Guanfacine XR here
News-ID: 4069583 • Views: …
More Releases from The Business Research Company
Growing Expenditure On Non-Medical Veterinary Services To Propel Pet Boarding Ma …
Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
What Is the Pet Boarding Services Market Size and Projected Growth Rate?
The market size of pet boarding services has seen robust growth in the past few years. It is projected that it will witness a growth from $6.96 billion in 2024 to $7.51 billion in 2025, recording a compound annual growth rate (CAGR)…
Central Nervous System (CNS) Lymphoma Market Anticipated To Witness Robust Growt …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Current Central Nervous System (CNS) Lymphoma Market Size and Its Estimated Growth Rate?
The market size for central nervous system (CNS) lymphoma has been experiencing robust growth in the past few years. The market, as projected, will escalate from $1.44 billion in 2024 to reach about $1.54 billion in…
Global Peracetic Acid Market Outlook 2025-2034: Trends, Innovations, And Future …
Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
What Is the Peracetic Acid Market Size and Projected Growth Rate?
The peracetic acid market has witnessed a fast-paced growth in its size over the last few years. It is projected to increase from $1.13 billion in 2024, to $1.25 billion in 2025, which implies a compound annual growth rate (CAGR) of 10.3%. The…
Cardiac Amyloidosis Market Size Projected To Reach 8.1 Billion By 2034 With A Ca …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Projected Growth of the Cardiac Amyloidosis Market?
In recent times, the market size of cardiac amyloidosis has seen significant growth. With the current projections, it is expected to increase from a market value of $5.26 billion in 2024 to $5.75 billion in 2025, with a compound annual growth rate…
More Releases for Attention
Attention-bias Modification Treatment App (ABMT)
Global Attention-bias Modification Treatment App Market Research Report is a resource, which provides current as well as upcoming technical and financial details of the industry to 2027. This report gives you so important and essentials data of Market size, share, trends, Growth, applications, forecast and cost analysis. Delivery development in North America, China, Europe, and South East Asia, Japan as well as in the Globe. The report proves to be indispensable when…
Attention Deficit Hyperactivity Treatment Disorder (ADHD) Market : A Market Surv …
Attention deficit hyperactivity disorder also known as hyperkinetic disorder/ neuropsychiatric disorder is one of the most common brain disorder characterized by symptoms of hyperactivity, inattention, and impulsivity. It is commonly observed in children above 12years age as compared to older population. The exact cause of the Attention Deficit Hyperactivity Disorder (ADHD) is not clear but, expected to be resulted due to improper functioning of the nervous system that led to…
Mining Industry Safety Attracts More Attention
A survey made on Wednesday by industrial software company Ventyx, a subsidiary of ABB, shows that mining industry safety is one of the three top concerns by mining executives, including employee safety, managing capital projects and maximising production effectiveness. This study makes the mining safety on the top position in mining industry.
The 2012 Worldwide Mining Survey analyzed new trends and shifting attitudes around workforces, capital investments and technology and…
ATTENTION EARTH!
It’s the year 2013, if you’re reading this Earth has shockingly survived the Mayan prediction and prophetic date of December 21st, 2012. Since this is being written in the past, it’s not certain what has happened to humankind. Did Earth collide with planet X? Or was the cataclysm of 2012 a positive physical and/or spiritual transformation for humanity. Be as it may, hopefully this day will mark the beginning of…
Home Staging Graduates Draw Attention from Media
(UNITED STATES) January 31, 2012 – Three home stagers, all graduates of the Staging Diva Training Program, were recently featured by the Chicago Tribune and other media outlets. They had previously completed a home staging training program that was founded by The Staging Diva, Debra Gould.
“Being featured in the media provides a significant boost to your credibility as a home staging expert in your market,” says Gould. “Do not underestimate…
The Gift of Attention Deficit Disorder
“Attention Deficit Disorder (ADD/ADHD) is an evolutionary process not a disability,” asserted Dr. Kevin, author of “Managing the Gift of Your ADD/HD Child” on Lon Woodbury’s Internet Talk Radio Show “Parent Choices for Struggling Teens” on October 17, 2011 at LATalkRadio at http://www.latalkradio.com.
“By the mid-19th century, society started to transition from physical survival being a top priority to one with advancements that allowed more time to focus on improving…
